Family Management Corp Geron Corp Transaction History

Family Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.2 - $1.5 $12,000 - $15,000	-10,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $12,500 - $18,300	10,000 New	10,000 $14,000
Q3 2020 Nov 13, 2020	SELL	$1.59 - $2.19 $16,059 - $22,119	-10,100 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$1.27 - $1.54 $127 - $154	-100 Reduced 0.98%	10,100 $14,000
Q4 2017 Feb 15, 2018	SELL	$1.8 - $2.32 $27,000 - $34,800	-15,000 Reduced 59.52%	10,200 $18,000
Q2 2017 Aug 18, 2017	BUY	N/A	25,200	25,200 $70,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

Stay updated on Family Management Corp with notifications on news.